Carter Bankshares, Inc. Form 8-K Summary
Business Context and Reporting Period
Carter Bankshares, Inc. (NASDAQ: CARE), the holding company for Carter Bank & Trust, filed this Current Report on March 26, 2026. The filing discloses the completion of a significant asset sale transaction involving nonperforming loans.
Key Financial Metrics and Transaction Details
- Transaction Proceeds: The Company received $289.48 million in cash from the sale of specific nonperforming loans.
- Asset Sold: Loans with an outstanding aggregate principal of $209.48 million, all of which were nonperforming and on nonaccrual status.
- Historical Reserve: As of December 31, 2025, the Company had recorded a specific reserve of $18.04 million against these loans.
- Pro Forma Impact (as of Dec 31, 2025):
- Total Assets: Approximately $4.95 billion.
- Total Loans: Approximately $3.67 billion.
- Allowance for Credit Losses: Approximately $53.46 million (1.46% of total loans).
- Nonperforming Loans: Approximately $29.96 million (0.82% of total loans).
- Historical Comparison (as of Dec 31, 2025):
- Total Assets: $4.85 billion.
- Total Loans: $3.88 billion.
- Allowance for Credit Losses: $71.49 million (1.84% of total loans).
- Nonperforming Loans: $243.98 million (6.29% of total loans).
- Shareholder Value: The transaction is estimated to favorably impact tangible book value per common share by approximately $3.49.
Material Changes Versus Prior Period
The transaction represents a material reduction in the Company's nonperforming loan portfolio. Pro forma, the nonperforming loan ratio is projected to decrease from 6.29% to 0.82% of total loans. Additionally, the allowance for credit losses ratio is projected to improve from 1.84% to 1.46%. The sale converted a significant portion of nonperforming assets into immediate cash liquidity.
Outlook, Risks, and Contingencies
The Company will provide detailed financial impacts in its upcoming earnings release and Form 10-Q for the quarter ended March 31, 2026. The filing includes standard forward-looking statement disclaimers, noting that actual results may differ due to market interest rates, changes in accounting policies (specifically CECL methodology), liquidity positions, and concentrations in commercial real estate loans. The pro forma information is unaudited and for illustrative purposes only.
Investor Verification Checklist
- Verify the final accounting treatment and gain/loss recognition in the Q1 2026 Form 10-Q.
- Confirm the updated tangible book value per share in the next earnings release.
- Review the composition of the remaining $29.96 million in pro forma nonperforming loans.
- Monitor the impact of the cash infusion on the Company's liquidity and capital ratios.